Connecticut is Home to Life Science Innovators & Researchers
Connecticut is a top destination for the Life Science industry. The state is home to a thriving life sciences community that is anchored by a robust ecosystem of cutting-edge research, highly educated workforce, and innovative companies.
From the artificial heart to stem cell study to genome research, Connecticut continues to demonstrate its commitment to serving as the center for biomedical advances. Connecticut has become a nucleus of life science advances—from groundbreaking research in personalized medicine to device manufacturing of the latest medical technology.
- 23,000 Employees at more than 1,300 Life Sciences Companies (TEConomy/BIO, 2020)
- #4 in Bioscience Patents per capita (TEConomy/BIO, 2020)
- 6th in the U.S.for NIH Funding per capita with $684 million (National Institutes of Health, 2021)
- Home to 38 World Class Colleges & Universities, including Yale and UConn
- #1 in Health IT adoption – a key indicator of healthcare innovation (Information Technology & Innovation Foundation, 2020)
- #2 for Academic Bioscience R&D Investments per capita (TEConomy/BIO, 2020)
- 80% of all Connecticut academic R&D investments are in bioscience (TEConomy/BIO, 2020)
- #2 in the nation patents per 1,000 individuals in science and engineering occupations. (National Science Foundation)
- 4th in the U.S. for Bioscience Venture Capital R&D Investments (BioCT, 2021)
- #5 in the Nation for Science & Engineering Doctorates in the Workforce (National Science Foundation, 2020)
Support for Connecticut’s Life Sciences Industry
Connecticut has invested in the life sciences industry. There is support for this growing industry and resources designed to promote the research and development of new technologies, along with the continued cultivation of talent.
“Connecticut’s universities are great engines of innovation. Those ideas attract capital, both from the private sector and public sector. Together, with Connecticut’s talent pool, those are the three ingredients for a successful bioscience company.”
- Arvinas Founder Craig Crews on launching a pharmaceutical enterprise in New Haven